Curaleaf Holdings (CURLF) Inventory Average (2019 - 2024)
Curaleaf Holdings (CURLF) recorded quarterly Inventory Average of $106.5 million in Q4 2024, up 3055.25% quarter-over-quarter from -$3.6 million in Q3 2024, and down 51.11% on a YoY basis from $217.9 million in Q1 2024.
Curaleaf Holdings (CURLF) Inventory Average (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Inventory Average history runs 6 years deep, the most recent figure standing at $106.5 million for Q4 2024.
- In Q4 2024, Inventory Average fell 51.11% year-over-year to $106.5 million; the TTM figure through Dec 2024 stood at $106.5 million (down 51.11% YoY), while the FY2025 annual figure was $221.0 million, up 2.1% from the prior year.
- Inventory Average was $106.5 million for Q4 2024 at Curaleaf Holdings, up from -$3.6 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $216.9 billion in Q2 2022 to a low of -$3.6 million in Q3 2024.
- Historically, Inventory Average has averaged $36.3 billion across 5 years, with a median of $251.6 million in 2021.
- The sharpest annual moves came in 2022 and 2024: Inventory Average soared 99536.33% in 2022, then sank 101.55% in 2024.
- A 5-year view of Inventory Average shows it stood at $190.4 million in 2020, then soared by 56.05% to $297.2 million in 2021, then jumped by 45.79% to $433.2 million in 2022, then tumbled by 49.71% to $217.9 million in 2023, then plunged by 51.11% to $106.5 million in 2024.
- The last three Inventory Average figures came in at $106.5 million (Q4 2024), -$3.6 million (Q3 2024), and $217.9 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 3.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 2.51 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 180.70 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 131.60 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 66.75 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 1.73 Bn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 266.66 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 63.01 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 79.60 Mn |
| 10 | Curaleaf Holdings | - | - | 157.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 106.52 Mn |
| Sep 30, 2024 | -3.60 Mn |
| Dec 31, 2023 | 217.89 Mn |
| Sep 30, 2023 | 232.29 Mn |
| Sep 30, 2022 | 433.25 Mn |
| Jun 30, 2022 | 216.92 Bn |
| Mar 31, 2022 | 216.83 Bn |
| Dec 31, 2021 | 297.18 Mn |
| Sep 30, 2021 | 325.43 Mn |
| Jun 30, 2021 | 270.95 Mn |
| Mar 31, 2021 | 217.62 Mn |
| Dec 31, 2020 | 190.43 Mn |
| Dec 31, 2019 | 17.54 Mn |